Anmelden

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar, it must undergo an additional phase II reaction. This subsequent reaction converts the nonpolar metabolite into a polar conjugate, enhancing its excretability. During hepatic drug oxidation, the oxidized form of P450 initially binds with the parent drug, creating a binary-drug complex. This complex is then reduced by NADPH–P450 reductase. Following this reduction, the complex uses molecular oxygen and another electron to form an "activated oxygen"-P450-substrate complex. The activated oxygen is then transferred to the drug, creating the oxidized drug metabolite. In conclusion, the monooxygenase P450 cycle plays a crucial role in a phase I reaction, oxidizing a parent drug and introducing a hydroxyl group.

Tags
Drug MetabolismPhase I ReactionsBiochemical ProcessCytochrome P450HemoproteinsEndoplasmic ReticulumPolar GroupMetaboliteHepatic Drug OxidationBinary drug ComplexNADPH P450 ReductaseActivated OxygenOxidized Drug MetaboliteMonooxygenase P450 Cycle

Aus Kapitel 3:

article

Now Playing

3.17 : Drug Metabolism: Phase I Reactions

Pharmacokinetics

2.8K Ansichten

article

3.1 : Pharmakokinetik: Überblick

Pharmacokinetics

4.6K Ansichten

article

3.2 : Absorptionsmechanismus von Medikamenten: Passiver Membrantransport

Pharmacokinetics

3.2K Ansichten

article

3.3 : Absorptionsmechanismus von Medikamenten: Trägervermittelter Membrantransport

Pharmacokinetics

3.1K Ansichten

article

3.4 : Arzneimittelabsorption: Faktoren, die die gastrointestinale Absorption beeinflussen

Pharmacokinetics

3.4K Ansichten

article

3.5 : Bioverfügbarkeit: Überblick

Pharmacokinetics

2.3K Ansichten

article

3.6 : Faktoren, die die Bioverfügbarkeit beeinflussen: First-Pass-Eliminierung

Pharmacokinetics

5.7K Ansichten

article

3.7 : Bioäquivalenz: Überblick

Pharmacokinetics

843 Ansichten

article

3.8 : Effekt "Erster Durchgang"

Pharmacokinetics

4.7K Ansichten

article

3.9 : Zeitverlauf der Arzneimittelwirkung

Pharmacokinetics

1.8K Ansichten

article

3.10 : Wirkstoffverteilung: Gewebebindung

Pharmacokinetics

2.3K Ansichten

article

3.11 : Physiologische Barrieren

Pharmacokinetics

3.1K Ansichten

article

3.12 : Wirkstoffverteilung: Plasmaproteinbindung

Pharmacokinetics

3.9K Ansichten

article

3.13 : Fächermodelle: Modell mit nur einem Fach

Pharmacokinetics

1.9K Ansichten

article

3.14 : Fächermodelle: Modell mit zwei Fächern

Pharmacokinetics

4.8K Ansichten

See More

JoVE Logo

Datenschutz

Nutzungsbedingungen

Richtlinien

Forschung

Lehre

ÜBER JoVE

Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten